Genetic variants associated with acamprosate treatment response in alcohol use disorder patients: A multiple omics study

BACKGROUND AND PURPOSE: Acamprosate is an anti‐craving drug used for the pharmacotherapy of alcohol use disorder (AUD). However, only some patients achieve optimal therapeutic outcomes. This study was designed to explore differences in metabolomic profiles between patients who maintained sobriety an...

Descripción completa

Detalles Bibliográficos
Autores principales: Ho, Ming‐Fen, Zhang, Cheng, Wei, Lixuan, Zhang, Lingxin, Moon, Irene, Geske, Jennifer R., Skime, Michelle K., Choi, Doo‐Sup, Biernacka, Joanna M., Oesterle, Tyler S., Frye, Mark A., Seppala, Marvin D., Karpyak, Victor M., Li, Hu, Weinshilboum, Richard M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9177536/
https://www.ncbi.nlm.nih.gov/pubmed/35016259
http://dx.doi.org/10.1111/bph.15795

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9177536/
https://www.ncbi.nlm.nih.gov/pubmed/35016259
http://dx.doi.org/10.1111/bph.15795

Ejemplares similares